Truthout
Drug Pricing
Trump Touts Generic Drug Approvals, But Many Won’t Be for Sale in US
Nearly half of newly approved generic drugs aren’t being sold in the United States.
Hospitals Must Now Publicly Reveal Their Prices
Starting this month, hospitals must publicly reveal the contents of their master price lists online.
Drug-Pricing Reforms Find New Momentum as “a 2020 Thing”
Lawmakers are pushing a bevy of new proposals on health care following the 2018 midterms.
Rebate Trap Keeps Generic Diabetes Drugs Out of Reach
Big Pharma brands keep generics out of the market by offering volume-based rebates to insurers and their intermediaries.
Warren-Schakowsky Bill Is a Huge Step Toward Bringing Drug Costs Down
A new bill would allow the federal government to create a manufacturing capacity in order to enter the drug market.
Sanders-Khanna Bill Would Stop Monopoly Drug Pricing in the US
The bill would likely reduce the price of most brand drugs by around 50 percent.
Type 1 Diabetics Need Affordable Insulin, Not “Innovation”
Diabetics should refuse to donate their data to Eli Lilly unless the company makes insulin affordable.
Critics Say Trump’s New Rule on Drug-Pricing Disclosure Doesn’t Go Far Enough
Drug pricing is a top issue in the run-up to the midterm elections.
Trump’s Attack on Medicare for All Has Industry Fingerprints All Over It
It’s no surprise that the health insurance industry went right to the White House.
Drug Makers Play the Patent Game to Lock in Prices, Block Competitors
No industry gets a greater financial return from its patent strategy than pharmaceuticals.